The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Activation of the Hippo transducer TAZ is emerging as a novel oncogenic route in breast cancer and it has been associated with breast cancer stem cells. Additionally, TAZ expression has been linked with HER-2 positivity. We investigated the association between TAZ expression and pathological complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Vici, Patrizia, Mottolese, Marcella, Pizzuti, Laura, Barba, Maddalena, Sperati, Francesca, Terrenato, Irene, Benedetto, Anna Di, Natoli, Clara, Gamucci, Teresa, Angelucci, Domenico, Ramieri, Maria Teresa, Lauro, Luigi Di, Sergi, Domenico, Bartucci, Monica, Dattilo, Rosanna, Pagliuca, Alfredo, Maria, Ruggero De, Maugeri-Saccà, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259424/
https://www.ncbi.nlm.nih.gov/pubmed/25294813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259424/
https://www.ncbi.nlm.nih.gov/pubmed/25294813

Ejemplares similares